Search Results - "Atef, Manal"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    HL-128 Simultaneous Hodgkin Lymphoma Diagnosis in 2 Sisters: Is This a Coincidence? by Atef, Manal

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)
    “…The genetic predisposition to lymphoma is not fully understood. The precise incidence of familial Hodgkin disease (HD) in first-degree relatives is not well…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    CML-029 Unexpected Turn of Events in an Egyptian Patient With Chronic Myeloid Leukemia (CML): Case Report by Atef, Manal

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…Tyrosine kinas inhibitors (TKIs) are the standard-ofcare treatment for CML. TKI-related renal adverse events (AEs) are rare and not well understood. Here we…”
    Get full text
    Journal Article
  6. 6
  7. 7

    MM-111 A Complex Journey of Multiple Myeloma, a Devastating Metastatic Breast Cancer, Then Multiple Myeloma Again: A Double Malignancy Case Report by Ibrahim, Ahmed, Atef, Manal

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)
    “…Multiple myeloma (MM) represents approximately 10% of hematologic malignancies. The incidence of nonhematologic malignancy in patients previously diagnosed…”
    Get full text
    Journal Article
  8. 8
  9. 9

    AML-109 When It Rains It Pours. A Case Report of Unexpected Double Malignancy in An Egyptian Female Patient by Ibrahim, Ahmed, Atef, Manal

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)
    “…There are very few reports of the coexistence of acute myeloid leukemia (AML) and breast cancer since 1965. Usually, this double malignancy carries poor…”
    Get full text
    Journal Article
  10. 10

    WNT3 and LEF1 as markers for diagnosis and survival prediction in chronic lymphocytic leukemia patients by Atef, Manal, Saleh, Layla M., Eisa, Noha, Shamaa, Sameh

    “…Summary Background The Wnt pathway is aberrantly activated in chronic lymphocytic leukemia (CLL) and contributes to the antiapoptotic and mitogenic…”
    Get full text
    Journal Article
  11. 11

    CLL-016: WNT3 and LEF1 Expression Levels and Outcome of Chronic Lymphocytic Leukemia in Egyptian Patients by Atef, Manal, Shamaa, Sameh, Eissa, Noha, Saleh, Layla

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)
    “…Chronic lymphocytic leukemia (CLL), a hematologic malignancy, characterized by progressive accumulation of mature B lymphocytes. The role of Wnt signaling…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    IBCL-010: Castleman Disease with Active Presentation in an Egyptian Female Patient: A Case Report by Shaaban, Yasmine, EL-Ashwah, Shaimaa, Elshamy, Alaa, Atef, Manal, E. Eladl, Ahmed, El-Sherpiny, S, R.Hendawy, Shaimaa, Elbogdady, Aya, Bogdady, Mohamed El

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2020)
    “…Castleman disease (CD) is a heterogeneous nonmalignant lymphoproliferative disorder characterized by lymphadenopathy with unique histological features and…”
    Get full text
    Journal Article
  18. 18
  19. 19